Illumina offers a growing menu of solutions enabling clinical laboratories to create and deploy NGS-based molecular diagnostic tests.
Regulated platforms with stringent performance characteristics for diagnostic use.
Next-generation sequencing panels for detection of causative and clinically relevant variants for cystic fibrosis.